Thermo Fisher Scientific
TMO
2,077 hedge funds and large institutions have $173B invested in Thermo Fisher Scientific in 2021 Q2 according to their latest regulatory filings, with 152 funds opening new positions, 857 increasing their positions, 748 reducing their positions, and 93 closing their positions.
63% more first-time investments, than exits
New positions opened: 152 | Existing positions closed: 93
15% more repeat investments, than reductions
Existing positions increased: 857 | Existing positions reduced: 748
10% more capital invested
Capital invested by funds: $157B → $173B (+$15.9B)
4% more funds holding in top 10
Funds holding in top 10: 149 → 155 (+6)
2% more funds holding
Funds holding: 2,042 → 2,077 (+35)
0.14% less ownership
Funds ownership: 87.49% → 87.35% (-0.14%)
8% less call options, than puts
Call options by funds: $1.12B | Put options by funds: $1.22B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.01B |
| 2 |
HSBC Holdings
London,
United Kingdom
|
+$471M |
| 3 |
GIM
Generation Investment Management
London,
United Kingdom
|
+$325M |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$316M |
| 5 |
Flossbach Von Storch
Cologne,
Germany
|
+$213M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$928M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$868M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$486M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$428M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$265M |
TMO Hedge Fund Activity: Q2 2021 in Review
2,077 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q2 2021, worth a combined $173B — up 10% from $157B a quarter earlier.
Buyers outnumbered sellers: 152 funds opened new TMO positions and 93 closed out — a net gain of 59 holders — while 857 added to existing stakes and 748 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $1.01B. The largest seller was Capital World Investors, cutting an estimated $928M.
- 2,077 institutional investors held Thermo Fisher Scientific (TMO) as of Q2 2021, up from 2,042 in Q1 2021.
- Funds reported $173B of Thermo Fisher Scientific stock for Q2 2021, up 10% quarter-over-quarter.
- 152 funds opened new Thermo Fisher Scientific positions in Q2 2021 and 93 closed out, a net change of +59 holders.
- The largest Thermo Fisher Scientific buyer in Q2 2021 was T. Rowe Price Associates, an estimated $1.01B added.
- The largest Thermo Fisher Scientific seller in Q2 2021 was Capital World Investors, an estimated $928M sold.
Based on aggregated 13F filings for Q2 2021.